Sevelamer Carbonate

For research use only. Not for therapeutic Use.

  • CAT Number: A000485
  • CAS Number: 845273-93-0
  • Molecular Formula: C7H14ClNO4
  • Molecular Weight: 211.642
  • Purity: ≥95%
Inquiry Now

Sevelamer carbonate (CAS 845273-93-0)&nbsp;is a non-absorbed phosphate binding crosslinked polymer, with the same polymeric structure as sevelamer hydrochloride, in which carbonate replaces chloride as the counterion.<br />
Sevelamer carbonate is designed as an alternative to sevelamer hydrochloride with enhanced buffering capacity. The sevelamer moiety consists of a carbon backbone with multiple amine groups, each separated from the backbone by a single carbon atom. In the intestine, Sevelamer carbonate become protonated and subsequently bind to dietary phosphorus molecules via ionic and hydrogen interactions. The result of these interactions is a decrease in phosphorus levels within the gastrointestinal tract, resulting in decreased dietary phosphorus absorption and decreased serum phosphorus levels. In addition to the effect on phosphorus levels, the polymeric amine structure of sevelamer has been shown to bind bile acids to reduces total cholesterol levels.Sevelamer Carbonate is able to reduce renal failure triggered inflammation and induced endotoxemia in experimental model of chronic kidney disease.


Catalog Number A000485
CAS Number 845273-93-0
Synonyms

NA

Molecular Formula C7H14ClNO4
Purity ≥95%
Storage 3 years -20C powder
IUPAC Name carbonic acid;2-(chloromethyl)oxirane;prop-2-en-1-amine
InChI InChI=1S/C3H5ClO.C3H7N.CH2O3/c4-1-3-2-5-3;1-2-3-4;2-1(3)4/h3H,1-2H2;2H,1,3-4H2;(H2,2,3,4)
InChIKey PADGNZFOVSZIKZ-UHFFFAOYSA-N
SMILES C=CCN.C1C(O1)CCl.C(=O)(O)O
Reference

<span style="color:#000000;"><span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;">1.<span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">Delmez, J., et al. &quot;A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px; font-variant-ligatures: normal; orphans: 2; widows: 2;">Clinical nephrology</i><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">&nbsp;68.6 (2007): 386.<br />
2.</span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">Barna, Mary M., Toros Kapoian, and Neeta Bahal O&#39;Mara. &quot;Sevelamer carbonate.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px; font-variant-ligatures: normal; orphans: 2; widows: 2;">Annals of Pharmacotherapy</i><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">&nbsp;44.1 (2010): 127-134.<br />
3.</span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">Hauser, Aline B., et al. &quot;Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px; font-variant-ligatures: normal; orphans: 2; widows: 2;">Blood purification</i><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">&nbsp;30.3 (2010): 153-158.</span></span></span></span>

Request a Quote